IPO registrations (S-1, F-1) · Registrants
SANGUI BIOTECH INTERNATIONAL INC
- SEC CIK
- 1104280 · filings on EDGAR ↗
- Former names
- FELNAM INVESTMENTS INC (2000–2000)
- Registration
- Form S-1, first filed 2015-06-25; 1 initial registration, 0 amendments
- Outcome
- Declared effective 2015-08-07
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- CO
- Business address
- 352 SOUTH 200 WEST, SUITE 3, Farmington, UT 84025
- EIN
- 84-1330732
- EDGAR entity type
- operating
- Insiders and CEO pay
- SANGUI BIOTECH INTERNATIONAL INC on the corporate pages
Offering terms
- Shares offered
- 30,000,000
- Listing
- OTCQB under the symbol SGBI
- Lead underwriters
- Tarpon Bay Partners, LLC 0 (30,000,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: SANGUI BIOTECH INTERNATIONAL INC EXACT (CIK (EXACT))
Filings 2
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2015-06-25 | S-1 | S-1 (registration) | SANGUI BIOTECH INTERNATIONAL INC | 0001551163-15-000153 ↗ |
| 2015-08-07 | EFFECT | EFFECT (declared effective) | SANGUI BIOTECH INTERNATIONAL INC | 9999999995-15-002216 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-06-25 | S-1 | registration statement | 30,000,000 | - | OTCQB SGBI | 1 | primary document; shares headline, underwriting table 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| FLEING JOACHIM | Director; Director,Officer | CFO; CFO, Secretary | 25 | 2007–2015 | |
| Joachim Lutz | Director | 4 | 2007–2008 | ||
| Striepe Thomas | Director; Director,Officer | CEO; ceo, President; CEO, President; CEO, President, CFO, Secretary; CEO< President, CFO, Secretary | 16 | 2007–2022 | |
| BARNIKOL WOLFGANG | Director; Director,Officer | CEO,CFO and President; President and CEO | 4 | 2007–2008 | |
| Schmelz Hubertus | Director | 14 | 2009–2022 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Patent assignee | Sangui BioTech International, Inc. | UT | Patents (USPTO) | name and state |
| SEC filer | SANGUI BIOTECH INTERNATIONAL INC | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, UT first:
- ZARS Pharma, Inc. UT
- Q Therapeutics, Inc. UT
- SignPath Pharma, Inc. UT
- THAT MARKETING SOLUTION, INC. UT
- REST EZ Inc. UT
- Clene Inc. UT
- ANESTA CORP /DE/ UT
- NovaCardia Inc CA
- MyoKardia, Inc. CA
- Bioquest Corp CA
In other datasets, the same topic (Health) in UT:
- Nonprofit: 19 HOPE AND HEALING (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health